home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

37.20 -0.58 (-1.52%)

Streaming Delayed Price Updated: 10:43 AM EST, Jan 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

AtriCure Releases 2023 ESG Report

November 14, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Third Quarter 2023 Financial Results

November 01, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the Stifel 2023 Healthcare Conference

October 31, 2023

From AtriCure, Inc.

Via Business Wire

What 7 Analyst Ratings Have To Say About AtriCure ↗

May 03, 2023

Via Benzinga

Analyst Ratings for AtriCure ↗

February 22, 2023

Via Benzinga

Earnings Outlook For AtriCure ↗

February 20, 2023

Via Benzinga

5 Analysts Have This to Say About AtriCure ↗

August 03, 2022

Within the last quarter, AtriCure (NASDAQ:ATRC) has observed the following analyst ratings:

Via Benzinga

AtriCure to Announce Third Quarter 2023 Financial Results

October 11, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Second Quarter 2023 Financial Results

July 25, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate at Upcoming Investor Conferences

July 21, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce Second Quarter 2023 Financial Results

July 03, 2023

From AtriCure, Inc.

Via Business Wire

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market ↗

May 24, 2023

Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne

Via Benzinga

AtriCure Reports First Quarter 2023 Financial Results

May 02, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

April 19, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce First Quarter 2023 Financial Results

April 11, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

April 03, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

February 21, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare Conference

February 17, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial

January 31, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference

January 24, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023

January 09, 2023

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

From AtriCure, Inc.

Via Business Wire

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday ↗

December 19, 2022

Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on...

Via Benzinga

AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award

December 08, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference

November 08, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Third Quarter 2022 Financial Results

November 01, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in Upcoming Investor Conferences

October 25, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce Third Quarter 2022 Financial Results

October 11, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Announces Investor Education Webcast with Hybrid AF Therapy Key Opinion Leaders

September 06, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

August 16, 2022

From AtriCure, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com